Search research articles
Contact Us
Filters
Showing results (91-100 of 232) with videos related to
Page
of 24
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 6, 2014
Long-term outcome of patients with Crohn's disease who discontinued infliximab therapy upon clinical remission
Konstantinos Papamichael, Niels Vande Casteele, Ann Gils, et al.
Gastroenterology
|
October 13, 2009
Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease
Filip Baert, Liesbeth Moortgat, Gert Van Assche, et al.
Digestive Diseases and Sciences
|
April 3, 2024
Ozanimod Differentially Impacts Circulating Lymphocyte Subsets in Patients with Moderately to Severely Active Crohn's Disease
Sarah Harris, Brian G Feagan, Stephen Hanauer, et al.
Inflammatory Bowel Diseases
|
April 2, 2005
Environmental factors in familial Crohn's disease in Belgium
Herbert J Van Kruiningen, Marie Joossens, Severine Vermeire, et al.
The American Journal of Gastroenterology
|
April 22, 2005
Tumor necrosis factor receptor gene polymorphisms in Crohn's disease: association with clinical phenotypes
Kevin A Waschke, Alexandra-Chloe Villani, Severine Vermeire, et al.
Journal of Clinical Gastroenterology
|
June 20, 2007
Familial Crohn's disease in Belgium: pedigrees, temporal relationships among cases, and family histories
Herbert J Van Kruiningen, Marie Joossens, Severine Vermeire, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
|
August 19, 2007
Search for evidence of recurring or persistent viruses in Crohn's disease
Herbert J Van Kruiningen, Michelle Poulin, Antonio E Garmendia, et al.
Journal of Crohn'S & Colitis
|
January 30, 2016
AVX-470, an Orally Delivered Anti-Tumour Necrosis Factor Antibody for Treatment of Active Ulcerative Colitis: Results of a First-in-Human Trial
M Scott Harris, Deborah Hartman, Brenda R Lemos, et al.
Computational and Structural Biotechnology Journal
|
December 23, 2021
Dysbiosis and relapse-related microbiome in inflammatory bowel disease: A shotgun metagenomic approach
Gerard Serrano-Gómez, Luis Mayorga, Iñigo Oyarzun, et al.
Gut
|
December 25, 2012
Butyricicoccus pullicaecorum in inflammatory bowel disease
Venessa Eeckhaut, Kathleen Machiels, Clémentine Perrier, et al.
Page
of 24
Search research articles
Search
Showing results (91-100 of 232) with videos related to
Sort By:
Page
of 24
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 6, 2014
Long-term outcome of patients with Crohn's disease who discontinued infliximab therapy upon clinical remission
Konstantinos Papamichael, Niels Vande Casteele, Ann Gils, et al.
Gastroenterology
|
October 13, 2009
Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease
Filip Baert, Liesbeth Moortgat, Gert Van Assche, et al.
Digestive Diseases and Sciences
|
April 3, 2024
Ozanimod Differentially Impacts Circulating Lymphocyte Subsets in Patients with Moderately to Severely Active Crohn's Disease
Sarah Harris, Brian G Feagan, Stephen Hanauer, et al.
Inflammatory Bowel Diseases
|
April 2, 2005
Environmental factors in familial Crohn's disease in Belgium
Herbert J Van Kruiningen, Marie Joossens, Severine Vermeire, et al.
The American Journal of Gastroenterology
|
April 22, 2005
Tumor necrosis factor receptor gene polymorphisms in Crohn's disease: association with clinical phenotypes
Kevin A Waschke, Alexandra-Chloe Villani, Severine Vermeire, et al.
Journal of Clinical Gastroenterology
|
June 20, 2007
Familial Crohn's disease in Belgium: pedigrees, temporal relationships among cases, and family histories
Herbert J Van Kruiningen, Marie Joossens, Severine Vermeire, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
|
August 19, 2007
Search for evidence of recurring or persistent viruses in Crohn's disease
Herbert J Van Kruiningen, Michelle Poulin, Antonio E Garmendia, et al.
Journal of Crohn'S & Colitis
|
January 30, 2016
AVX-470, an Orally Delivered Anti-Tumour Necrosis Factor Antibody for Treatment of Active Ulcerative Colitis: Results of a First-in-Human Trial
M Scott Harris, Deborah Hartman, Brenda R Lemos, et al.
Computational and Structural Biotechnology Journal
|
December 23, 2021
Dysbiosis and relapse-related microbiome in inflammatory bowel disease: A shotgun metagenomic approach
Gerard Serrano-Gómez, Luis Mayorga, Iñigo Oyarzun, et al.
Gut
|
December 25, 2012
Butyricicoccus pullicaecorum in inflammatory bowel disease
Venessa Eeckhaut, Kathleen Machiels, Clémentine Perrier, et al.
Page
of 24